AACR logo

More articles from Models and Technologies

High-Throughput Generation of Bispecific Binding Proteins by Sortase A–Mediated Coupling for Direct Functional Screening in Cell Culture
Fabio Andres, Martin Schwill, Ykelien L. Boersma, Andreas Plückthun

Molecular Cancer Therapeutics Apr 2020, 19 (4) 1080-1088; DOI: 10.1158/1535-7163.MCT-19-0633
Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease
Myungeun Lee, Zhi Hong Lu, Jie Li, Elena A. Kashentseva, Igor P. Dmitriev, Samir A. Mendonca, David T. Curiel

Molecular Cancer Therapeutics Mar 2020, 19 (3) 966-971; DOI: 10.1158/1535-7163.MCT-19-0768
Therapeutic Breast Reconstruction Using Gene Therapy–Delivered IFNγ Immunotherapy
Christopher R. Davis, Peter A. Than, Sacha M.L. Khong, Melanie Rodrigues, Michael W. Findlay, Daniel J. Navarrete, Shadi Ghali, Jayant S. Vaidya, Geoffrey C. Gurtner

Molecular Cancer Therapeutics Feb 2020, 19 (2) 697-705; DOI: 10.1158/1535-7163.MCT-19-0315
Hyaluronidase-Expressing Salmonella Effectively Targets Tumor-Associated Hyaluronic Acid in Pancreatic Ductal Adenocarcinoma
Nancy D. Ebelt, Edith Zuniga, Kevin B. Passi, Lukas J. Sobocinski, Edwin R. Manuel

Molecular Cancer Therapeutics Feb 2020, 19 (2) 706-716; DOI: 10.1158/1535-7163.MCT-19-0556
The First Clinical Use of a Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E7 Oncogene Oral Vaccine: A Phase I Safety and Immunogenicity Trial in Healthy Women Volunteers
Amir Hossein Mohseni, Sedigheh Taghinezhad-S, Hossein Keyvani

Molecular Cancer Therapeutics Feb 2020, 19 (2) 717-727; DOI: 10.1158/1535-7163.MCT-19-0375
Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood–Brain Barrier
Synnøve Nymark Aasen, Heidi Espedal, Christopher Florian Holte, Olivier Keunen, Tine Veronika Karlsen, Olav Tenstad, Zaynah Maherally, Hrvoje Miletic, Tuyen Hoang, Anne Vaag Eikeland, Habib Baghirov, Dag Erlend Olberg, Geoffrey John Pilkington, Gobinda Sarkar, Robert B. Jenkins, Terje Sundstrøm, Rolf Bjerkvig, Frits Thorsen

Molecular Cancer Therapeutics Nov 2019, 18 (11) 2171-2181; DOI: 10.1158/1535-7163.MCT-19-0160
An EGFR-Induced Drosophila Lung Tumor Model Identifies Alternative Combination Treatments
Judith Bossen, Karin Uliczka, Line Steen, Roxana Pfefferkorn, Mandy Mong-Quyen Mai, Lia Burkhardt, Michael Spohn, Iris Bruchhaus, Christine Fink, Holger Heine, Thomas Roeder

Molecular Cancer Therapeutics Sep 2019, 18 (9) 1659-1668; DOI: 10.1158/1535-7163.MCT-19-0168
Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing
Sunetra Das, Rupa Idate, Kathryn E. Cronise, Daniel L. Gustafson, Dawn L. Duval

Molecular Cancer Therapeutics Aug 2019, 18 (8) 1460-1471; DOI: 10.1158/1535-7163.MCT-18-1346
Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing
Jasmien Cornillie, Agnieszka Wozniak, Haifu Li, Yannick Wang, Bram Boeckx, Yemarshet K. Gebreyohannes, Jasmien Wellens, Ulla Vanleeuw, Daphne Hompes, Marguerite Stas, Friedl Sinnaeve, Hazem Wafa, Diether Lambrechts, Maria Debiec-Rychter, Raf Sciot, Patrick Schöffski

Molecular Cancer Therapeutics Jun 2019, 18 (6) 1168-1178; DOI: 10.1158/1535-7163.MCT-18-1045
Preclinical Investigation of ²¹²Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model
Tania A. Rozgaja Stallons, Amal Saidi, Izabela Tworowska, Ebrahim S. Delpassand, Julien J. Torgue

Molecular Cancer Therapeutics May 2019, 18 (5) 1012-1021; DOI: 10.1158/1535-7163.MCT-18-1103

Main menu

User menu

Search

More articles from Models and Technologies

Pages

Articles

Info for

About MCT